11:10-12:00, Rm 103

More documents

Recommendations

Info

Reactive Oxygen Species and Cell SignalingS6-4The role of posttranslational modification of Oct4 in induced pluripotentstem cellsHyonchol Jang, Tae-Wan Kim, Hong-Duk YounDepartment of Biomedical Sciences, Seoul National University College of Medicine, Seoul 110-799,KoreaThe study on induced pluripotent stem (iPS) cells field has been booming because of itspotential for an exciting research tool to probe mammalian development and epigeneticreprogramming as well as therapeutic potential for custom-tailored cell therapy.Reprogramming of somatic cells to iPS cells has been achieved by the expression ofseveral embryonic stem cell specific transcription factors such as Oct4, Sox2, and Klf4.To understand the signaling pathways directly regulating these factors duringreprogramming, we investigated the posttranslational modifications (PTMs) on them. Aftersetting up Oct4, Sox2, and Klf4 - driven reprogramming of mouse embryonic fibroblastsinto iPS cells, we determined the effect of PTMs on reprogramming efficiency. Inhibition ofsome PTMs by introducing point mutants of Oct4 and/or Sox2 greatly affected onreprogramming efficiency. More detailed information will be discussed in this symposium.S7-3Romo1 is a molecular bridge between TNF-αsignaling and themitochondria for ROS production that triggers TNF-α-mediated liverinjuryYoung Do YooLaboratory of Molecular Cell Biology, Graduate School of Medicine, Korea University College ofMedicine, Korea UniversityReactive oxygen species (ROS) produced by tumor necrosis factor-α(TNF-α) have animportant function in cell death by activating c-Jun N-terminal kinase. However, the exactmechanism of mitochondrial ROS production, after TNF-αstimulation, is not clearlyunderstood. In this study, we determined that ROS modulator 1 (Romo1) and B-celllymphoma-extra large (Bcl-XL) are directly associated with TNF-α-induced ROSproduction. In response to TNF-α, TNF complex II, which consists of receptor interactingprotein 1 (RIP1), TNF receptor-associated protein with death domain (TRADD), TNFreceptor-associated factor 2 (TRAF2), Fas-associated death domain protein (FADD), andpro-caspase-8, binds to the C-terminus of Romo1 located in the mitochondria.Concurrently, Romo1 recruits Bcl-XL to reduce the mitochondrial membrane potential,resulting in ROS production and apoptotic cell death. The increased cell death and DNAdamage were observed in the liver of the Romo1-transgenic mice treated with LPS (lipopolysaccharide)and D-GalN (galactosamine), compared to normal mice. On the basis ofthese results, we suggest that Romo1 is a molecular bridge between TNF-αsignaling andthe mitochondria for ROS production that triggers TNF-α-mediated apoptosis, contributingto chronic liver diseases. We also suggest that Romo1 is the novel target in thedevelopment of anti-inflammatory agents that block the origin of ROS production.S7-1Selective regulatory role of H2O2 in RTK signalingSang Won KangDepartment of Life Science, Division of Life and Pharmaceutical Sciences, Ewha WomansUniversity, Seoul 120-750, KoreaThe receptors for platelet-derived growth factor (PDGF) and vascular endothelial growthfactor (VEGF) are representative members of receptor tyrosine kinase (RTK) family.Since PDGF and VEGF are the key growth factors orchestrating mitogenic andchemoattractic responses of vascular endothelial and smooth muscle cells, respectively,both signaling pathways are coordinatelyin volved in the vascular maturation andremodeling. Here I talk about the role of H2O2 in these two RTK signaling. We havepreviously shown that a thioredoxin-dependent peroxide reductase, peroxiredoxin II (PrxII), suppresses neointimal hyperplasia of vascular smooth muscle cells by negativelyregulating PDGF signaling. Recently, we found that Prx II positively regulates VEGFsignaling in vascular endothelial cells by protecting VEGFR-2 tyrosine kinase activityagainst oxidative inactivation. As a new result, ablation of Prx II in human aorticendothelial cells results in the oxidative inactivation of VEGFR-2 tyrosine kinase.Collectively, I will present that H2O2 plays an important regulatory role in RTK signalingand PrxII is a novel reciprocal modulator in vascular cells.S7-4Regulation of NADPH oxidase in innate immunityYun Soo BaeDepartment of Life Science, Ewha Womans UniversityReactive oxygen species (ROS), including hydrogen peroxide and superoxide anion, aregenerally considered cytotoxic. However in recent years, many reports havedemonstrated that intracellular ROS, produced in mammalian cells in response to theactivation of various receptors, serve as important second messengers in cell signaling.Recently we reported that NADPH oxidase (Nox) isozymes can be activated by toll-likereceptors (TLRs), which are key regulators of innate immunity. We showed that thestimulation of TLR4 complex with LPS as exogenous agonist or mmLDL as endogenousligand induces reactive oxygen species (ROS) generation and NF-κB activation and thatthis process is mediated by the regulation of Nox isozymes. Moreover, we demonstratedthat Nox-dependent ROS generation plays an important role in LPS- and mmLDLinducedproinflammatory cytokine production by endothelial cells (EC) and macrophages,respectively, leading to adhesion molecule expression on surface of EC and migration ofvascular cells. To extend this research, we investigated molecular connection betweenTLRs and Nox isozymes using yeast two hybrid and GST pull-down assay. In thisseminar, I will introduce and discuss the activation patterns of Nox isozymes by TLR andits pathological events.S7-2TNF signaling, ROS, and cancerZhenggang LiuCell and Cancer Biology Branch, NCI, NIH, USATumor necrosis factor (TNF) is a proinflammatory cytokine that plays a critical role indiverse cellular events, including cell proliferation, differentiation and apoptosis. TNF isalso involved in many types of diseases. The regulation of apoptosis is critical forcontrolling tissue homeostasis and Reactive Oxygen Species (ROS) generation plays akey role in the process. ROS are known to be involved in mediating TNF signaling.Recent findings on the role of ROS in regulating TNF-induced apoptosis and cancer willbe discussed. Particularly, we describe a novel HIF-1 target, ATIA (anti-TNF-inducedapoptosis), which protects cells against TNF- and hypoxia-induced apoptosis. Importantly,ATIA protects cells from apoptosis through regulating the function of the mitochondrialantioxidant enzyme, thioredoxin 2 and the generation of ROS.74 Korean Society for Biochemistry and Molecular BiologyS8-1Structural biology of ECM proteinsJihye Yun¹, Youngsil Choi², Ji-ho Yoo³, Bon-Kyung Koo¹, Hyun-Soo Cho³, Eok-Soo Oh²and Weontae Lee¹*¹Department of Biochemistry, College of Life Science & Biotechnology, Yonsei University, Seoul 120-749,Korea, ²Department of Life Sciences, Division of Life and Pharmaceutical Sciences and the Center for CellSignaling & Drug Discovery Research, Ewha Womans University, Seoul 120-750, Korea, ³Departmentof Biology, College of Life Science & Biotechnology, Yonsei University, Seoul 120-749, KoreaMost of the biological function results from protein-protein/ligand interactions via their ability tocommunicate their information. The communication process in a cell has been recently studiedin the point of protein-protein or protein-lipid interactions by structural biology. NMRspectroscopy and X-ray crystallography together with biophysical techniques could be powerfulmethods in probing protein-protein interactions. The scaffold PDZ-domain containing proteinsyntenin binds to the cytoplasmic domain of syndecans, but little is known about underlyingmechanisms and the function of syntenin-1-syndecan interaction. Here we provide the evidencefor an inhibitory role of syntenin-1 on syndecan-4 functions based on structure-function analysis.Crystal structure shows that two PDZ domains of syntenin with syndecan-4 are arranged as ananti-parallel fashion, forming a symmetric dimer with a propeller shape. The syndecan dimer isexposed mostly to solvent. The structures of syntenin/syndecan/PIP2 complex forms asymmetric dimer anchored by a syndecan dimer and it provides the functional insight forsyntenin related to syndecan-4 function. Consistent to this notion, syntenin-1 decreased bindingof PKCa to syndecan-4 cytoplasmic domain via PDZ2 domain, with concomitant decrease inPKCa activity in vitro. In addition, syndecan-1 expression caused reduced FRET betweensyndecan-4 and the catalytic domain of PKCa. Furthermore, both syntenin-1 and synteninPDZ2 domain reduced PKCa localization to focal adhesions and inhibited syndecan-4-mediated functions such as focal adhesion formation and cell migration reduction.
Structure and Function of Extracellular Matrix, Stem Cell and Differentiation-KNIH Joint Symposium
Page 2 and 3:
SecretariatKorean Society for Bioch
Page 4 and 5:
345710111359616498160354404Invitati
Page 6 and 7:
General InformationRegistrationRegi
Page 8 and 9:
Science ManagerMin-Seon KimAsan Med
Page 10 and 11:
Tuesday, May 17, 2011Time8:00-9:00G
Page 12 and 13:
Hall InformationSeminar | Grand Bal
Page 14 and 15:
The poster board surface area is 95
Page 16 and 17:
Nobel Laureate LectureMay 17 (Tue),
Page 18 and 19:
KMA Plenary LectureMay 16 (Mon), 15
Page 20 and 21:
Moosa Plenary LectureMay 17 (Tue),
Page 22 and 23:
Donghun Award LectureSang-Hun LeeDe
Page 24 and 25:
Chungsan Award LectureSue Goo RheeD
Page 26 and 27: Macrogen Woman Scientist Award Lect
Page 28 and 29: Achievement Award of Paper - BMB re
Page 30 and 31: Most Citation Paper Award - BMB rep
Page 32 and 33: Most Number of Paper Award - BMB re
Page 34 and 35: Merck Young Scientist Award Lecture
Page 36 and 37: SymposiaS1Stem Cells and Cancer Ste
Page 38 and 39: S3Aging and Mitochondria May 16 (Mo
Page 40 and 41: S5Cell Cycle and Genetic Stability
Page 42 and 43: S7Reactive Oxygen Species and Cell
Page 44 and 45: S9Stem Cell and Differentiation-KNI
Page 46 and 47: S11G-protein Coupled Receptors and
Page 48 and 49: S13Development and Model Organisms
Page 50 and 51: S15Innate Immunity and Host-Microbe
Page 52 and 53: S17Neurodevelopment and Regeneratio
Page 54 and 55: S19Cardiovascular Disease May 18 (W
Page 56 and 57: Biomedical Lecture SeriesBLS1Autoph
Page 58 and 59: BLS3Angiogenesis and Vascular Disea
Page 60 and 61: BLS5Inflammation and Immunity May 1
Page 62 and 63: Bio-Medical Science Co., LtdMay 17
Page 65 and 66: 2011KSBMBAnnual MeetingStepping int
Page 67: KMA Plenary LectureNuclear receptor
Page 70 and 71: Donghun AwardStem cell biology for
Page 72 and 73: Stem Cells and Cancer Stem Cells, C
Page 74 and 75: The Early Stage of Plant Developmen
Page 78 and 79: Stem Cell and Differentiation-KNIH
Page 80 and 81: TGF-βSignaling and Its Therapeutic
Page 82 and 83: Post-Transcriptional Regulation and
Page 84 and 85: Neurodevelopment and RegenerationS1
Page 86 and 87: Cardiovascular Diseaseoxidant, redu
Page 91 and 92: Neurodegenerative Disease, Angiogen
Page 93: Inflammation and Immunity
Page 96 and 97: GE Healthcare Ltd.High content anal
Page 101 and 102: Poster Session List
Page 127 and 128:
Poster Session List
Page 129 and 130:
Poster Session List
Page 131 and 132:
Poster Session List
Page 133 and 134:
Poster Session List
Page 135 and 136:
Poster Session List
Page 137 and 138:
Poster Session List
Page 139 and 140:
Poster Session List
Page 141 and 142:
Poster Session List
Page 143 and 144:
Poster Session List
Page 145 and 146:
Poster Session List
Page 147 and 148:
Poster Session List
Page 149 and 150:
Poster Session List
Page 151 and 152:
Poster Session List
Page 153 and 154:
Poster Session List
Page 155 and 156:
Poster Session List
Page 157 and 158:
Poster Session List
Page 159 and 160:
Poster Session List
Page 161 and 162:
2011KSBMBAnnual MeetingStepping int
Page 163 and 164:
Bioinformatics and systems biology
Page 165 and 166:
Page 167:
Page 170 and 171:
Cancer biologyB-17-01TrkC plays an
Page 172 and 173:
Cancer biologyB-17-13Syntenin posit
Page 174 and 175:
Cancer biologyB-17-25Role of CBR1 i
Page 176 and 177:
Cancer biologyB-17-38Secretory leuk
Page 178 and 179:
Cancer biologyB-17-50Thymoquinone (
Page 180 and 181:
Cancer biologyB-17-62Omega-3 polyun
Page 182 and 183:
Cancer biologyB-17-74Identification
Page 184 and 185:
Cancer biologyB-17-86Elevated fibro
Page 186 and 187:
Cancer biologyB-17-98Tissue inhibit
Page 188 and 189:
Cancer biologyB-17-111Sox10 control
Page 190 and 191:
Cancer biologyB-17-123Rsf-1 (HBXAP)
Page 192 and 193:
Cancer biologyB-17-135Syndecan-2 re
Page 194 and 195:
Cancer biologyB-17-147Involvement o
Page 196 and 197:
Cancer biologyB-17-159Overexpressio
Page 198 and 199:
Cancer biologyB-17-171IEX-1 is a cr
Page 200 and 201:
Cancer biologyB-17-183Clinical vali
Page 202 and 203:
Cell: differentiation, division and
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 219 and 220:
Page 221 and 222:
Chemical biology and drug discovery
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229:
Page 232 and 233:
Development and regenerationE-17-01
Page 234 and 235:
Page 236 and 237:
Page 238 and 239:
Lipids and carbohydratesF-17-01Chan
Page 240 and 241:
MicrobiologyG-17-01Fatty acids incr
Page 242 and 243:
MicrobiologyG-17-13MARCH5, a mitoch
Page 244 and 245:
MicrobiologyG-17-25Discovery of che
Page 246 and 247:
NeuroscienceH-17-01N-Adamantyl-4-me
Page 248 and 249:
NeuroscienceH-17-12Inhibition of do
Page 250 and 251:
NeuroscienceH-17-24Neuroprotective
Page 252 and 253:
NeuroscienceH-17-37A novel BDNF-mod
Page 254 and 255:
NeuroscienceH-17-49Differential alt
Page 256 and 257:
NeuroscienceH-17-61Effect of volunt
Page 259 and 260:
Page 261:
Plant biology
Page 264 and 265:
Protein: structure and functionJ-17
Page 266 and 267:
Page 268 and 269:
Page 270 and 271:
Page 272 and 273:
Biotechnology and bioengineeringK-1
Page 274 and 275:
Biotechnology and bioengineeringK-1
Page 277 and 278:
Page 279 and 280:
Cell: signal transduction
Page 281 and 282:
Page 283 and 284:
Page 285 and 286:
Page 287 and 288:
Page 289 and 290:
Page 291 and 292:
Page 293 and 294:
Page 295:
Cell: structure and physiology
Page 298 and 299:
Genetics and genomics, epigeneticsN
Page 300 and 301:
Page 302 and 303:
Page 304 and 305:
Page 306 and 307:
ImmunologyO-18-01Cilostazol protect
Page 308 and 309:
ImmunologyO-18-14IL-18 is an import
Page 310 and 311:
ImmunologyO-18-26Functions of novel
Page 312 and 313:
ImmunologyO-18-39KIAA1542 gene prod
Page 315 and 316:
Page 317 and 318:
Metabolism and metabolic diseases
Page 319 and 320:
Page 321 and 322:
Page 323:
Page 326 and 327:
Molecular medicine and imagingQ-18-
Page 329 and 330:
Page 331 and 332:
Protein: modification and regulatio
Page 333 and 334:
Page 335:
Proteomics
Page 338 and 339:
RNA biologyT-18-01Genome-wide funct
Page 340 and 341:
RNA biologyT-18-14Rapid molecular d
Page 342 and 343:
OthersU-18-01Use of non-melanocytic
Page 344 and 345:
OthersU-18-13Sulfuretin inhibits UV
Page 346 and 347:
OthersU-18-25Suppressed expression
Page 348 and 349:
OthersU-18-37Mismatch-repair relate
Page 350 and 351:
OthersU-18-49AIP2, one of AROS inte
Page 352 and 353:
Launching new technologies from the
Page 354 and 355:
KSBMB’s NEXT MEETINGSSorak Confer
Page 356 and 357:
354Exhibition Booth Layout
Page 358 and 359:
기기전시 상호명별 부스번
Page 360 and 361:
(주)기산바이오텍 부스번
Page 362 and 363:
(주)대한과학 부스번호 : 16
Page 364 and 365:
(주)메카시스 부스번호 : 61
Page 366 and 367:
l(주)비바젠 부스번호 : 151,
Page 368 and 369:
(주)아토코리아 부스번호 :
Page 370 and 371:
(주)월드사이언스 부스번
Page 372 and 373:
천양테크 부스번호 : 38lCHUN
Page 374 and 375:
한국바이오래드 주식회사
Page 376 and 377:
Product Indexactivity monitoring동
Page 378 and 379:
iochemicals고마바이오텍㈜ 10
Page 380 and 381:
싸토리우스 코리아 바이오
Page 382 and 383:
cuvettes, elecroporation㈜고려
Page 384 and 385:
싸토리우스 코리아 바이오
Page 386 and 387:
enzyme immunoassay kits고마바이
Page 388 and 389:
㈜대명사이언스 159㈜디케
Page 390 and 391:
implantable instrumentation서린
Page 392 and 393:
micromanipulators㈜라이카 코
Page 394 and 395:
㈜휴컴시스템 137oxygen uptake
Page 396 and 397:
㈜대명사이언스 159㈜부경
Page 398 and 399:
㈜인실리코젠 133㈜케이오
Page 400 and 401:
한독바이오테크㈜ 64tissue c
Page 402 and 403:
Bio Job Fair 2011May 17 ~ 18, 2011H
Page 405 and 406:
Page 407 and 408:
U-18-06Cho, Young Jae ……B-17-18
Page 409 and 410:
Jang, Sei-Heon ………G-17-03Jang
Page 411 and 412:
P-18-31, S-18-08Kim, Jeewoong …
Page 413 and 414:
LLee, Areum …………P-18-29Lee,
Page 415 and 416:
Moon, Yun-Won ……C-17-81Morgan,
Page 417 and 418:
Shin, Jae-Sun ………J-17-31Shin,
show all

11:10-12:00, Rm 103

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?